Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Aetna Inc    AET

AETNA INC (AET)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Goldman M&A head Sykes joins management committee

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/19/2012 | 11:07pm CEST

Gene Sykes, global head of Goldman Sachs Group Inc's (>> Goldman Sachs Group, Inc.) mergers and acquisitions business, has been named to the investment bank's management committee, according to an internal memo.

Gene Sykes, global head of Goldman Sachs Group Inc's (>> Goldman Sachs Group, Inc.) mergers and acquisitions business, has been named to the investment bank's management committee, according to an internal memo.

The 54-year-old investment banker joins 28 other executives on the powerful committee, which includes Chief Executive Lloyd Blankfein and Chief Operating Officer Gary Cohn, and influences decisions about Goldman's business strategy and operations.

Sykes' appointment comes just nine days after the departure of another prominent Goldman banker, Yoel Zaoui, was announced in a separate internal memo. Zaoui shared the title of M&A co-head with Sykes and had also been on the management committee.

Sykes, who is based in Los Angeles, is also chairman of the global technology, media and telecommunications department of the investment banking division. He is a member of Goldman's internal Business Standards Committee.

The Goldman veteran joined the firm in 1984 and became a partner in 1992. He has advised on several high-profile deals, including Walt Disney Co's (>> The Walt Disney Company) acquisition of Pixar, Aetna Inc's (>> Aetna Inc.) acquisition of U.S. Healthcare and Roche Holding AG acquisition of Genentech.

"Gene has played a vital role in strengthening our investment banking franchise, particularly with respect to many of the most significant companies in technology and media," Blankfein and Cohn said in the memo, whose contents were confirmed by a spokesman.

(Reporting By Lauren Tara LaCapra in New York; editing by Andre Grenon)

By Lauren Tara LaCapra

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AETNA INC
09/19 AETNA : Announces New Accountable Care Product in Tennessee Leveraging the Vande..
09/16 ANTHEM : insurance to stay in area ACA market
09/11 AETNA INC /PA/ : Regulation FD Disclosure (form 8-K)
09/08 AETNA : Offers Assistance to Members Affected by Hurricane Irma
09/06 AETNA : Executive to Present at CEO Investor Forum 2.0
09/04 AETNA : Texas Health Aetna adds to executive leadership team
09/01 AETNA : The Day, New London, Conn., David Collins column
08/31 AETNA : Signs Sponsorship Agreement with University of Virginia Athletics
08/29 AETNA : Executive to Present at Morgan Stanley Global Healthcare Conference
08/29 AETNA : Mailing in n.j. may have exposed hiv status
More news
News from SeekingAlpha
09/19 Senate hearing on Graham-Cassidy bill
09/14 No leaving healthcare behind
08/22 Tracking Larry Robbins' Glenview Capital Management Portfolio - Q2 2017 Updat..
08/21 Fixing Healthcare - Transforming The Role Of Insurance
08/17 CNBC reveals what Apple and Aetna discussed about the Watch
Financials ($)
Sales 2017 60 925 M
EBIT 2017 4 419 M
Net income 2017 1 950 M
Debt 2017 -
Yield 2017 0,95%
P/E ratio 2017 26,12
P/E ratio 2018 16,68
Capi. / Sales 2017 0,88x
Capi. / Sales 2018 0,84x
Capitalization 53 468 M
Chart AETNA INC
Duration : Period :
Aetna Inc Technical Analysis Chart | AET | US00817Y1082 | 4-Traders
Technical analysis trends AETNA INC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 166 $
Spread / Average Target 3,2%
EPS Revisions
Managers
NameTitle
Mark T. Bertolini Chairman & Chief Executive Officer
Karen S. Lynch President
Margaret M. McCarthy Executive Vice President-Operations & Technology
Shawn M. Guertin CFO, Executive VP & Chief Enterprise Risk Officer
Harold L. Paz Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
AETNA INC31.18%53 468
UNITEDHEALTH GROUP23.83%191 622
ANTHEM INC29.78%48 578
CIGNA CORPORATION38.92%46 654
HUMANA INC22.18%35 905
CENTENE CORP69.85%16 313